Ian Karp | Senior Vice President of Investor Relations & Corporate Communications |
John Leonard | Chief Executive Officer |
David Lebwohl | Chief Medical Officer |
Laura Sepp-Lorenzino | Chief Scientific Officer |
Glenn Goddard | Chief Financial Officer |
Maury Raycroft | Jefferies |
Joon Lee | Truist Securities |
Luca Issi | RBC Capital Markets |
Jay Olson | Oppenheimer & Co. |
Steve Seedhouse | Raymond James |
Silvan Tuerkcan | JMP Securities |
Jack Allen | Robert W. Baird & Co, |
Yanan Zhu | Wells Fargo |
Tony Butler | ROTH Capital |
Good morning and welcome to the Intellia Therapeutics Second Quarter 2021 Financial Results Conference Call. My name is Jason and I will be your conference operator today.
As a reminder, all participants are currently in listen-only mode. [Operator Instructions] Following formal remarks, we will open the call up for questions. This conference is being recorded at the company's request and will be available on the company's website following the end of the call.